MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-TS-20-0011633
Spansules Pharmatech Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹73.76 Cr
▼ 4% YoY
Net profit · FY 2025
₹1.73 Cr
Net margin 2.3%
EBITDA · FY 2025
₹8.06 Cr
EBITDA margin 10.9%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹5 Cr
Issued & subscribed
Open charges
₹57.24 Cr
Satisfied ₹8 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
52
Provident fund records
About Spansules Pharmatech Private Limited
Data last updated:
Spansules Pharmatech Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 October 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2000PTC035421. Its GSTIN is 36AAFCS7057K1ZW (Telangana). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹5 Cr. It is led by directors including Venkata Subba Rao Guttikonda (Managing Director) and Rama Devi Guttikonda.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.59 G – 3 Sri Venkateswara Towers Bhagyanagar Colony, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹73.76 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹1.73 Cr (net margin 2.3%) and EBITDA of ₹8.06 Cr (EBITDA margin 10.9%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 5% over five years.
The company has about 52 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Spansules Pharmatech and Spansules. As per MCA filings, the company has open charges of ₹57.24 Cr and satisfied charges of ₹8 Cr on record. Court records list 9 cases involving the company, including 9 filed by the company; 4 cases are pending. The company has 4 deals on record (2 funding rounds, 2 rights issues), with disclosed funding of ₹1.83 Cr; the latest was in August 2023. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Atlas Pharmachem Industries Private Limited with revenue of ₹74.83 Cr.
Spansules Pharmatech Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0011633). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website spansulespharma.com.
Company Details of Spansules Pharmatech Private Limited
CIN U24230TG2000PTC035421
Registration Number 035421
Incorporation Date 09 October 2000
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-20-0011633
CIN History of Spansules Pharmatech Private Limited
Spansules Pharmatech has one previous CIN (Corporate Identification Number): U24230AP2000PTC035421. The current CIN is U24230TG2000PTC035421, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG2000PTC035421 | Current |
| U24230AP2000PTC035421 | Previous |
Key People
Venkata Subba Rao Guttikonda Managing Director Rama Devi Guttikonda Director Haswanth Rao Guttikonda Director Recognitions & Rankings of Spansules Pharmatech
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No.59 G – 3 Sri Venkateswara Towers Bhagyanagar Colony, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Spansules Pharmatech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Spansules Pharmatech Private Limited
Spansules Pharmatech operates two associated brands: Spansules Pharmatech and Spansules. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A WHO GMP and ISO 9001:2008 certified manufacturer and exporter of pharmaceutical pellets. | spansulespharma.net | |
| Pharmaceutical pellet manufacturing and formulation development in India. | spansulespharma.com |
Business Activity of Spansules Pharmatech Private Limited
The main business activity of Spansules Pharmatech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Spansules Pharmatech Private Limited FY 2025 filings available
Spansules Pharmatech Private Limited reported revenue of ₹73.76 Cr (down 4% YoY) for FY 2025.
Revenue · FY 2025
₹73.76 Cr ▼ 4%
Net profit · FY 2025
₹1.73 Cr margin 2.3%
EBITDA · FY 2025
₹8.06 Cr margin 10.9%
Compounded Annual Growth Rate (CAGR) of Spansules Pharmatech Private Limited
Revenue CAGR growth
1 year
▼ 4%
3 years · compounded
▼ 2%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 21%
5 years · compounded
▲ 15%
Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Spansules Pharmatech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹8.06 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.73 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Spansules Pharmatech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Spansules Pharmatech are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Spansules Pharmatech Private Limited
Spansules Pharmatech has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rama Devi Guttikonda | Director | 09 Oct 2000 | 26 Years 0 Months | Current |
| Haswanth Rao Guttikonda | Director | 07 Feb 2020 | 6 Years 8 Months | Current |
| Harika Rao Guttikonda | Director | 07 Feb 2020 | 6 Years 8 Months | Current |
| Venkata Subba Rao Guttikonda | Managing Director | 09 Oct 2000 | 26 Years 0 Months | Current |
Peer Comparison of Spansules Pharmatech Private Limited
Spansules Pharmatech Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Atlas Pharmachem Industries Private Limited | ₹74.83 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Ahmedabad, Gujarat, India |
| Casid Pharmaceuticals Private Limited | ₹74.41 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Manachanalloor, Tamil Nadu, India |
| Unispeed Pharmaceuticals Private Limited | ₹74.03 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Baddi, Himachal Pradesh, India |
| Johnlee Pharmaceuticals Private Limited | ₹73.78 Cr (FY 2024) | •••• | •••• | 39.0% | •••• | Mumbai, Maharashtra, India |
| Crest Healthcare Private Limited | ₹73.78 Cr (FY 2025) | •••• | •••• | 100.0% | •••• | Mumbai, Maharashtra, India |
| Spansules Pharmatech Private Limited this company | ₹73.76 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Hyderabad, Telangana, India |
| Shiva Biogenetic Laboratories Private Limited | ₹73.64 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Baddi, Himachal Pradesh, India |
| Ramson Medical Distributors Private Limited | ₹73.14 Cr (FY 2024) | •••• | •••• | 31.0% | •••• | Chennai, Tamil Nadu, India |
| Avn Ayurveda Formulations Private Limited | ₹72.9 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Madurai, Tamil Nadu, India |
| Eskay Herbal Formulations Private Limited | ₹72.88 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Jalgaon, Maharashtra, India |
| Kyowa Hakko Bio India Private Limited | ₹72.82 Cr (FY 2020) | •••• | •••• | 74.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Spansules Pharmatech by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Spansules Pharmatech Private Limited
Spansules Pharmatech Private Limited is audited by RAO&SIVAASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAO&SIVAASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Spansules Pharmatech Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Spansules Pharmatech Private Limited
Open charges
₹57.24 Cr
Satisfied charges
₹8 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Sep 2025 | Canara Bank | ₹2 Cr | Open |
| 10 May 2022 | Hdfc Bank Limited | ₹20 Lakh | Open |
| 08 Feb 2022 | Hdfc Bank Limited | ₹24.77 Cr | Open |
| 27 May 2015 | Canara Bank | ₹8 Lakh | Open |
| 21 Oct 2010 | Canara Bank | ₹3 Lakh | Open |
Total charge records: 8 View all charges
Deals & Funding of Spansules Pharmatech Private Limited
Spansules Pharmatech Private Limited has 4 deals on record (2 funding rounds, 2 rights issues), with disclosed funding of ₹1.83 Cr; the latest was in August 2023.
Total deals
4
Funding rounds
2
Rights issues
2
Disclosed funding
₹1.83 Cr
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2023 | Rights issue | ₹1.77 Cr | Investors: 2 individuals |
| Mar 2016 | Rights issue | ₹1.26 Cr | Investors: 4 individuals |
| Apr 2012 | Funding round | ₹96.1 Lakh | Investors: 2 individuals |
| Oct 2009 | Funding round | ₹86.5 Lakh | Investors: 2 individuals |
Premium access
Full deal history
All 4 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Spansules Pharmatech Private Limited
Spansules Pharmatech Private Limited has 9 court cases on record: 9 filed by Spansules Pharmatech. 4 cases are pending and 5 are disposed. Status as checked between 29 Sep 2026 and 04 Oct 2026.
Total cases
9
Filed by the company
9
Pending
4
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 0 | 4 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed by the company against Delius Pharmaceuticals Private Limited | Pending |
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed by the company against Vivimed Labs Limited | Disposed |
| District court, Medak, Telangana | Civil suit | Filed by the company against L P Polymers Limited | Disposed |
| District court, Medchal Malkajgiri, Telangana | Cheque dishonour complaint | Filed by the company against Solatium Pharmaceuticals | Pending |
| High Court of Andhra Pradesh | Writ petition | Filed by the company against State of Ap | Disposed |
Premium access
Full case history
All 9 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Spansules Pharmatech Private Limited
Spansules Pharmatech Private Limited has a workforce of 52 employees as of Sep 25, 2025.
Employee count
52
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Spansules Pharmatech Private Limited
Spansules Pharmatech Private Limited has 4 board changes on record since 2000: 4 appointments. The latest: Harika Rao Guttikonda was appointed as Director on 07 Feb 2020.
AGM
Spansules Pharmatech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Canara Bank amounted to Rs. 2.00 Cr with Charge ID 101198090 was registered on 19 Sep 2025.
Filing
Spansules Pharmatech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Canara Bank of Rs. 30.13 Cr registered on 13 Jun 2002 with Charge ID 90128215 was modified on 21 Jan 2023.
Charges
A charge with Hdfc Bank Limited of Rs. 24.77 Cr registered on 08 Feb 2022 with Charge ID 100540796 was modified on 07 Jun 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 100586682 was registered on 10 May 2022.
Charges
A charge registered on 23 Sep 2021 via Charge ID 100483729 with Others was fully satisfied on 29 Mar 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 24.77 Cr with Charge ID 100540796 was registered on 08 Feb 2022.
Charges
A charge with Others amounted to Rs. 8.00 Cr with Charge ID 100483729 was registered on 23 Sep 2021.
Appointed
Harika Rao Guttikonda was appointed as Director.
Appointed
Haswanth Rao Guttikonda was appointed as Director.
Charges
A charge with Canara Bank amounted to Rs. 0.08 Cr with Charge ID 10575835 was registered on 27 May 2015.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Spansules Pharmatech Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Spansules Pharmatech Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Spansules Pharmatech Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Spansules Pharmatech Private Limited
Spansules Pharmatech has 4 GST registrations: 2 active and 2 cancelled or inactive.
Total GSTINs
4
Active
2
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCS7057K1ZW | Telangana | Active | 01 Jul 2017 |
| 37AAFCS7057K3ZS | Andhra Pradesh | Active | 29 Mar 2020 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Spansules Pharmatech Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spansules Pharmatech Private Limited
Spansules Pharmatech is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 October 2000 (26+ years old) and is registered under CIN U24230TG2000PTC035421.
Spansules Pharmatech reported revenue of ₹73.76 Cr for FY 2025 (down 4% YoY).
Spansules Pharmatech has 4 current directors:
- Venkata Subba Rao Guttikonda - Managing Director
- Rama Devi Guttikonda - Director
- Haswanth Rao Guttikonda - Director
- Harika Rao Guttikonda - Director
Spansules Pharmatech reported a net profit of ₹1.73 Cr (net margin 2.3%) and EBITDA of ₹8.06 Cr (EBITDA margin 10.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Spansules Pharmatech is -2% over three years and 5% over five years. In the latest year (FY 2025) revenue fell 4%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Spansules Pharmatech is 36AAFCS7057K1ZW, registered in Telangana. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 37AAFCS7057K3ZS (Andhra Pradesh).
The CIN (Corporate Identification Number) of Spansules Pharmatech is U24230TG2000PTC035421. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spansules Pharmatech has 9 court cases on record: 9 filed by the company. 4 are pending. Most are in the district courts.
Spansules Pharmatech was incorporated on 09 October 2000, making it 26+ years old. It is registered with the Registrar of Companies, Hyderabad.
Spansules Pharmatech has 4 deals on record (2 funding rounds, 2 rights issues), with disclosed funding of ₹1.83 Cr; the latest was in August 2023.
The peers of Spansules Pharmatech by revenue are Atlas Pharmachem Industries Private Limited, Casid Pharmaceuticals Private Limited, Unispeed Pharmaceuticals Private Limited, Johnlee Pharmaceuticals Private Limited, Crest Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations).